XW4-32846-56390
3 vaccinations
2 coded responses
22 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 325 / FL
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body achesAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Pfizer-BioNTech
-
2021-02-09
Health check-in — day 7, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-06
-
2022-02-02
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Covid+MedDRA releases: 2024-11 · check-in free text available
-
2022-02-02
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-08
Call successfulParticipant prefers to complete VAERS report online
-
2022-06-08
Dose 3 — Pfizer-BioNTech
- 2022-06-29
- 2022-07-07
- 2022-07-15
- 2022-07-20
-
2022-12-09
Survey response — 6 months, dose 3MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Flu Nov 27MedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-12-12
- 2023-06-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2022-06-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-02 | Successful 2022-02-08 |
Participant prefers to complete VAERS report online |
| 2022-12-09 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Symptoms: Covid+
Release 12 — 6 months, dose 3
Symptoms: Flu Nov 27
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release